VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
Host Responses
VaximmutorDB
VIGET
Vaxafe
Vaxar
Vaxism
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UM Logo

HA

Gene Name HA
Sequence Strain (Species/Organism) Influenza A virus (A/duck/Badung-Bali/05/2005(H5N1))
VO ID VO_0011118
NCBI Protein GI 190344179
Other Database IDs CDD:278910
Taxonomy ID 1661658
Gene Strand (Orientation) ?
Protein Name hemagglutinin
Protein pI 6.67
Protein Weight 58202.54
Protein Length 623
Protein Note subtype: H5N1
Protein Sequence
>ABG20467.2 hemagglutinin, partial [Influenza A virus (A/duck/Badung/05/2005(H5N1))]
DQICIGYHANNSTEQVDTIMEKNVTVTHAKDILEKTHNGKLCDLDGVKPLILRDCSVAGWLLGNPMCDEF
TNVPEWSYIVEKANPANDLCYPGNFNDYEELKHLLSRINHFEKIQIIPKSSWSDHEASLGVSSACPYQGQ
SSFFRNVVWLIKKNSAYPTIKRSYNNTNQEDLLVLWGIHHPNDAAEQTRLYQNPTTYISVGTSTLNQRLV
PKIATRSKVNGQSGRMEFFWTIFKPNDAINFESNGNFIAPEYAYKIVKKGDSAIMKSELEYGNCNTECQT
PMGAINSSMPFHNIHPLTIRECPKYMKSSRLVLATGLRNSPQGERRRKKRGLFGAIAGFIEGGWQGMVDG
WYGYHHSNEQGSGYAADKESTQKAIDGVTNKVNSIIDKMNTQFEAVGREFNNLERRIENLNKKMEDGFLD
VWTYNAELLVLMENERTLDFHDSNVKNLYDKVRLQLKDNAKELGNGCFEFYHKCDNECMESIRNGTYNYP
QYSEEARLKREEISGVKLESIGTYQILSIYSTVASSLAL

Molecule Role Protective antigen
Molecule Role Annotation Mice vaccinated with a recombinant VLP vaccine from both influenza A H5N1 clade 1 and clade 2 isolates (Influenza A virus (A/duck/Badung-Bali/05/2005(H5N1))) with pandemic potential were protected against challenge with lethal reassortant viruses expressing the H5N1 HA and NA, regardless if the H5N1 clade was homologous or heterologous to the vaccine (Bright et al., 2008).
References